ID: ALA5269800

Max Phase: Preclinical

Molecular Formula: C12H17NO3

Molecular Weight: 223.27

Associated Items:

Representations

Canonical SMILES:  Cc1cc(=O)c(O)c(CN2CCCCC2)o1

Standard InChI:  InChI=1S/C12H17NO3/c1-9-7-10(14)12(15)11(16-9)8-13-5-3-2-4-6-13/h7,15H,2-6,8H2,1H3

Standard InChI Key:  CUBQYAUDOIVNDG-UHFFFAOYSA-N

Associated Targets(non-human)

Mycolicibacterium smegmatis 8003 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 223.27Molecular Weight (Monoisotopic): 223.1208AlogP: 1.64#Rotatable Bonds: 2
Polar Surface Area: 53.68Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.52CX Basic pKa: 7.13CX LogP: 1.26CX LogD: 1.06
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.83Np Likeness Score: -0.10

References

1. He M, Fan M, Peng Z, Wang G..  (2021)  An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery.,  221  [PMID:34023737] [10.1016/j.ejmech.2021.113546]

Source